Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects.
Nov 7, 2025
0
0









